U.S. markets open in 43 minutes

agilon health, inc. (AGL)

NYSE - NYSE Delayed Price. Currency in USD
18.06+0.50 (+2.85%)
At close: 04:00PM EST
18.06 0.00 (0.00%)
Pre-Market: 08:30AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close17.56
Bid0.00 x 1100
Ask29.97 x 800
Day's Range17.58 - 18.32
52 Week Range14.36 - 28.36
Avg. Volume2,036,372
Market Cap7.438B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.00
Earnings DateMar 01, 2023 - Mar 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • agilon health, inc.
    ALE: Raising target price to $73.00ALLETE INC has an Investment Rating of HOLD; a target price of $73.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • Business Wire

    agilon health to Participate in Wolfe Research Healthcare Conference

    AUSTIN, Texas, November 07, 2022--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 4th Annual Wolfe Research Healthcare Conference including a fireside chat presentation on Thursday, November 17 at 1:20 PM Eastern Time.

  • Zacks

    Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

    Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    agilon health Reports Third Quarter 2022 Results

    AUSTIN, Texas, November 03, 2022--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter ended September 30, 2022.